Atlas Trials

Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors

Clinical trial NCT04565769 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04565769
Sponsor
Aarhus University Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
MelanomaCognitive ImpairmentFatigueSleepDepression, AnxietyQuality of LifeInflammationSickness BehaviorCancer-related Cognitive Impairment
Start date
2020-11-12
Primary completion
2025-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.